Current guidelines suggest that an early invasive strategy should be considered for the treatment of NSTEMI. Although CKD is common among NSTEMI patients, these patients are underrepresented in clinical trials, and data regarding their management is limited.
Editors
JACC: Cardiovascular Interventions Editor-in-ChiefDavid J. Moliterno, MD, FACC
JACC: Cardiovascular Interventions CME/MOC/ECME EditorMichael C. McDaniel, MD
AuthorAmir Sharon, MD
Important Dates
Date of Release: October 3, 2022Term of Approval/Date of CME/MOC/ECME Expiration: October 2, 2023